Ardelyx (ARDX) Other Accumulated Expenses (2013 - 2020)
Ardelyx (ARDX) reported Other Accumulated Expenses of $285000.0 for Q4 2020, down 61.95% on a YoY basis from $749000.0 in Q1 2020, and down 61.95% quarter-over-quarter from $749000.0 in Q4 2019.
Ardelyx (ARDX) Other Accumulated Expenses (2013 - 2020) Analysis & Trends
Ardelyx has reported Other Accumulated Expenses for 8 years, with the latest figure at $285000.0 in Q4 2020.
- For the quarter ending Q4 2020, Other Accumulated Expenses fell 61.95% year-over-year to $285000.0; the trailing twelve-month figure through Dec 2020 stood at $285000.0 (down 61.95% YoY), and the FY2020 full-year result was $285000.0, down 61.95% from the prior year.
- Other Accumulated Expenses for Q4 2020 stood at $285000.0, down from $749000.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $984000.0 in Q1 2018, with the low at $170000.0 in Q3 2019.
- Historically, Other Accumulated Expenses has averaged $623000.0 across 5 years, with a median of $700000.0 in 2017.
- The largest YoY upside for Other Accumulated Expenses was 98.15% in 2019 against a maximum downside of 82.58% in 2019.
- Ardelyx's Other Accumulated Expenses stood at $684000.0 in 2016, then gained by 9.94% to $752000.0 in 2017, then plunged by 49.73% to $378000.0 in 2018, then surged by 98.15% to $749000.0 in 2019, then plunged by 61.95% to $285000.0 in 2020.
- The last three Other Accumulated Expenses figures came in at $285000.0 (Q4 2020), $749000.0 (Q4 2019), and $170000.0 (Q3 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 285,000.00 |
| Dec 31, 2019 | 749,000.00 |
| Sep 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 222,000.00 |
| Mar 31, 2019 | 211,000.00 |
| Dec 31, 2018 | 378,000.00 |
| Sep 30, 2018 | 976,000.00 |
| Jun 30, 2018 | 844,000.00 |
| Mar 31, 2018 | 984,000.00 |
| Dec 31, 2017 | 752,000.00 |
| Sep 30, 2017 | 700,000.00 |
| Jun 30, 2017 | 855,000.00 |
| Mar 31, 2017 | 647,000.00 |
| Dec 31, 2016 | 684,000.00 |
| Sep 30, 2016 | 824,000.00 |
| Jun 30, 2016 | 771,000.00 |
| Mar 31, 2016 | 539,000.00 |
| Dec 31, 2015 | 380,000.00 |
| Sep 30, 2015 | 845,000.00 |
| Dec 31, 2014 | 780,000.00 |